Effect of IL-18 on the release of IL-6 and its soluble receptors: sIL-6Rα and sgp130 by human neutrophils

Immunological Investigations

Volumn 31, Issue 3-4, 2002, Pages 159-167

  Jablonska, Ewa ^a   Jablonski, J ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Interleukin 18; Interleukin 6; Neutrophils; Soluble gp130; Soluble interleukin 6 receptor

Indexed keywords

GLYCOPROTEIN GP 130; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; IL6ST PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; RECOMBINANT PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; ADULT; CELL CULTURE; CHEMISTRY; CULTURE MEDIUM; DRUG EFFECT; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION; SOLUBILITY;

ADULT; ANTIGENS, CD; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYTOKINE RECEPTOR GP130; HUMANS; INFLAMMATION; INTERLEUKIN-18; INTERLEUKIN-6; MEMBRANE GLYCOPROTEINS; NEUTROPHILS; RECEPTORS, INTERLEUKIN-6; RECOMBINANT PROTEINS; SOLUBILITY;

EID: 0036439787     PISSN: 08820139     EISSN: None     Source Type: Journal    
DOI: 10.1081/IMM-120016237     Document Type: Article

References (16)

1. Dinarello, C.A.; Novick, D.; Puren, A.J.; Fantuzzi, G.; Shapiro, L.; Mühl, H.; Yoon, D.; Reznikov, L.L.; Kim, S.; Rubinstein, M. Overview of interleukin-18: More than an interferon-γ inducing factor. J. Leukoc. Biol. 1998, 63 (6), 658-664.
2. McInnes, I.B.; Gracie, J.A.; Leung, B.P.; Wei, X.Q.; Liew, F.Y. Interleukin 18: A pleiotropic participant in chronic inflammation. Immunol. Today 2000.
3. Leung, B.P.; Culshaw, S.; Gracie, J.A.; Hunter, D.; Canetti, C.A.; Campbell, C.; Cunha, F.; Liew, F.Y.; McInnes, I.B. A role for IL-18 in neutrophil activation. J. Immunol. 2001, 167 (3), 2879-2886.
4. Torigoe, K.; Ushio, S.; Okura, T.; Kobayashi, S.; Taniai, M.; Kunikata, T.; Murakami, T.; Sanou, O.; Kojima, H.; Fujii, M.; Ohta, T.; Ikeda, M.; Ikegami, H.; Kurimoto, M. Purification and characterization of the human interleukin-18 receptor. J. Biol. Chem. 1997, 272 (41), 25,737-25,742.
5. Lebel-Binay, S.; Berger, A.; Zinzindohoué, F.; Cugnenc, P.H.; Thiounn, N.; Fridman, W.H.; Pagés, F. Interleukin-18: Biological properties and clinical implications. Eur. Cytokine Netw. 2000, 11 (1), 15-25.
6. Debets, R.; Timans, J.C.; Churakowa, T.; Zurawski, S.; de Waal Malefyt, R.; Moore, K.W.; Abrams, J.S.; O'Garra, A.; Bazan, J.F.; Kastelein, R.A. IL-18 receptors, their role in ligand binding and function: Anti-IL-1RacPL antibody, a potent antagonist of IL-18. J. Immunol. 2000, 165 (2), 4950-4956.
7. Leite-de-Moraes, M.C.; Hameg, A.; Pacilio, M.; Koezuka, Y.; Taniguchi, M.; Van Kaer, L.; Schneider, E.; Dy, M.; Herbelin, A. IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: A pro-Th2 effect of IL-18 exerted through NKT cells. J. Immunol. 2001, 166 (2), 945-951.
8. + human blood mononuclear cells. J. Clin. Invest. 1998, 101 (3), 711-721.
9. Jablonska, E.; Izycka, A.; Jablonski, J.; Wawrusiewicz, N.; Piecuch, J. Role of IL- 18 in the secretion of IL-1β, sIL-1RII, and IL-1Ra by human neutrophils. Immunol. Invest. 2001, 30 (3), 221-229.
10. Heaney, M.L.; Golde, D.W. Soluble receptors in human disease. J. Leukocyte Biol. 1998, 64, 135-146.
11. Jones, S.A.; Horiuchi, S.; Topley, N.; Yamamoto, N.; Fuller, G.M. The soluble interleukin 6 receptor: Mechanisms of production and implications in disease. FASEB J. 2001, 15 (1), 43-58.
12. Gaillard, J.P.; Mani, J.C.; Liautard, J.; Klein, B.; Brochier, J. Interleukin-6 receptor signaling. I. gp80 and gp130 receptor interaction in the absence of interleukin-6. Eur. Cytokine Netw. 1999, 10 (1), 43-48.
13. Kishimoto, T.; Akira, S.; Narazaki, M.; Taga, T. Interleukin-6 family of cytokines and gp130. Blood 1995, 86 (2), 1243-1249.
14. Xing, Z.; Gauldie, J.; Cox, G.; Baumann, H.; Jordana, M.; Lei, X.F.; Achong, M.K. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 1998, 101 (2), 311-320.
15. Penton-Rol, G.; Orlando, S.; Polentarutti, N.; Bernasconi, S.; Muzio, M.; Introna, M.; Mantovani, A. Bacterial lipopolysaccharide causes rapid shedding, followed by inhibitor of mRNA expression, of the IL-1 type II receptor, with concomitant up-regulation of the type I receptor and induction of incompletely spliced transcripts. J. Immunol. 1999, 162 (3), 2931-2938.
16. Müller-Newen, G.; Küster, A.; Hemmann, U.; Keul, R.; Horsten, U.; Martens, A.; Graeve, L.; Wijdenes, J.; Heinrich, P.C. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses. J. Immunol. 1998, 161 (2), 6347-6355.